Donor Alliance Reports Record-Breaking 2025, Honoring and Saving More Lives Than Ever
Donor Alliance Marks Record-Breaking 2025, Saving More Lives Than Ever in Colorado and Wyoming Despite a period of major change in the national organ donation and transplantation landscape, Donor Alliance has achieved historic results in 2025, reaching new heights in…
LuskinOIC Establishes Research Award Celebrating the Legacy of Dr. Harry A. McKellop
LuskinOIC Establishes New Research Award to Honor Legacy of Dr. Harry A. McKellop The Luskin Orthopaedic Institute for Children (LuskinOIC) has announced the creation of a new research award designed to recognize and celebrate exceptional achievement and innovation in orthopaedic…
Dental Intelligence Names Scott Johnson as Chief Executive Officer
Dental Intelligence Appoints Scott Johnson as CEO to Lead Next Phase of Growth and Innovation Dental Intelligence, a leading provider of practice performance solutions for the dental industry, today announced that its Board of Directors has appointed Scott Johnson as…
Life Sciences Ontario Announces 2026 Awards Celebrating Excellence and Innovation
Life Sciences Ontario Announces 2026 Awards Celebrating Excellence, Leadership, and Innovation Across the Life Sciences Sector Life Sciences Ontario (LSO) has announced the recipients of the 2026 LSO Awards, recognizing outstanding leadership, innovation, and service across Ontario’s dynamic life sciences…
QIAGEN Announces Appointment of Mark Stevenson to Supervisory Board
QIAGEN Appoints Mark Stevenson to Supervisory Board, Strengthening Governance and Operational Expertise QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA), a global leader in sample and assay technologies serving molecular diagnostics, life sciences research, and applied testing markets, has announced the…
CorriXR Therapeutics Publishes New Preclinical Data on Restored Chemosensitivity
CorriXR Therapeutics Publishes Peer-Reviewed Preclinical Study Demonstrating CRISPR-Based NRF2 Editing Restores Chemosensitivity in Treatment-Resistant Solid Tumors CorriXR Therapeutics, an oncology-focused biotherapeutics company developing next-generation genetic medicines to overcome drug resistance in solid tumors, has announced the publication of new peer-reviewed…
SAP and Fresenius Drive Faster Digital Transformation in Healthcare
Leveraging AI and Cloud Solutions to Enhance Patient Care and Operational Efficiency SAP and Fresenius today announced that both companies intend to enter a strategic partnership to accelerate innovation for stronger digital healthcare delivery. Together, the companies plan to create…
Working Together to Ensure Reliable Vaccine Distribution This Flu Season
Strengthening supply chains and partnerships to deliver timely flu vaccines nationwide Vaccine distribution places higher demands on logistics than many other types of pharmaceuticals. Volumes rise sharply during the flu season, delivery windows are narrow and temperature control must hold…
EU In-Vitro Diagnostic Regulation (IVDR) Intro Course | Apr 2026
IVDR (EU 2017/746) Overview Training | Online, Apr 16–17, 2026 ResearchAndMarkets has announced the addition of the “Introduction to the In-Vitro Diagnostic Regulation (IVDR) Training Course (April 16–17, 2026)” to its growing portfolio of professional development and regulatory training programs.…
Organon Receives FDA Approval to Extend NEXPLANON Duration of Use
Organon Receives FDA Approval to Extend NEXPLANON Use to Five Years, Expanding Long-Acting Contraceptive Options for Women Organon a global healthcare company dedicated to improving women’s health outcomes, has announced a significant regulatory milestone with the approval by the U.S.…
ACES Announces Acquisition of Ally Pediatric Therapy
ACES Expands Arizona Footprint With Acquisition of Ally Pediatric Therapy, Strengthening Access to High-Quality ABA Services Across Greater Phoenix ACES, a leading clinically driven provider of autism therapy services in the United States, today announced the acquisition of Ally Pediatric…
FillPoint Health, US Heart & Vascular Expand Access to Innovative Cardiovascular Therapies
FillPoint Health, a URAC- and ACHC-accredited specialty pharmacy and management services organization (MSO) and a Lyceum Company, today announced the continued expansion of its strategic partnership with US Heart & Vascular (USHV), a leading national cardiovascular practice network. The collaboration…